Aze Technology Inc is categorized under Commercial Medical Research in Cambridge, MA and active since 2013.
Aze Technology Inc was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Shogo Azemoto at the company’s single location by writing to 1 Broadway Floor 14, Cambridge, Massachusetts MA 02142 or by phoning (617) 475-1502. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aze Technology Inc |
| Contact Person: | Shogo Azemoto |
| Address: | 1 Broadway Floor 14, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 475-1502 |
| Website Address: | azetech.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Aze Technology Inc was started in 2013 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Shogo Azemoto for inquiries that concern Aze Technology Inc by calling the company number (617) 475-1502, as your correspondence is most welcome. Additionally, the physical location of the single location of Aze Technology Inc can be found at the coordinates 42.362362,-71.083313 as well as the street address 1 Broadway Floor 14 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Aze Technology Inc’s website at azetech.com and engage with its social media outlets through on Twitter and on Facebook.